Andrea Cipriani

Active 2003–2025

206
Papers
39,603
Citations
94
h-index
197
i10-index

Citations

Citations per year for Andrea Cipriani1984: 1 citations1986: 3 citations2000: 1 citations2001: 3 citations2003: 3 citations2004: 5 citations2005: 9 citations2006: 19 citations2007: 31 citations2008: 34 citations2009: 95 citations2010: 91 citations2011: 113 citations2012: 128 citations2013: 159 citations2014: 176 citations2015: 215 citations2016: 214 citations2017: 239 citations2018: 263 citations2019: 1,107 citations2020: 1,416 citations2021: 1,532 citations2022: 1,336 citations2023: 1,103 citations2024: 1,956 citations2025: 887 citations2026: 52 citations1985: no citations, so this year is not shown1987–1999: no citations, so these years are not shown2002: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,891 citing papers, 16.7% of this breakdownUnited Kingdom: 2,030 citing papers, 11.7% of this breakdownChina: 1,282 citing papers, 7.4% of this breakdownGermany: 1,129 citing papers, 6.5% of this breakdownCanada: 1,064 citing papers, 6.2% of this breakdownItaly: 895 citing papers, 5.2% of this breakdownAustralia: 815 citing papers, 4.7% of this breakdownSpain: 568 citing papers, 3.3% of this breakdownNetherlands: 564 citing papers, 3.3% of this breakdownSwitzerland: 477 citing papers, 2.8% of this breakdownJapan: 402 citing papers, 2.3% of this breakdownDenmark: 365 citing papers, 2.1% of this breakdown
0%16.7%Other 27.8%

Fields

  • Medicine57.6%
  • Psychology14.7%
  • Neuroscience13.4%
  • Biochemistry, Genetics and Molecular Biology4.8%
  • Health Professions1.8%
  • Decision Sciences1.5%
  • Other6.2%

Topics

  • Treatment of Major Depression6.6%
  • Schizophrenia research and treatment6.5%
  • Bipolar Disorder and Treatment4.7%
  • Tryptophan and brain disorders4.7%
  • Attention Deficit Hyperactivity Disorder2.1%
  • Digital Mental Health Interventions2.1%
  • Other73.3%

Coauthors

All papers

Open in search
  1. Comparative Efficacy and Acceptability of 21 Antidepressant Drugs for the Acute Treatment of Adults With Major Depressive Disorder: A Systematic Review and Network Meta-Analysis

    Authors: , , , , , , , , , , , , , , , , , - FOCUS The Journal of Lifelong Learning in Psychiatry 2018 cited by 3,459

  2. Comparative Efficacy and Tolerability of 32 Oral Antipsychotics for the Acute Treatment of Adults With Multi-Episode Schizophrenia: A Systematic Review and Network Meta-Analysis

    Authors: , , , , , , , , , , , , - FOCUS The Journal of Lifelong Learning in Psychiatry 2019 cited by 1,744

  3. Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis

    Authors: , , , , , , , , , , , , , , , , , , - The Lancet Psychiatry 2018 cited by 1,333

  4. Comparative effects of 18 antipsychotics on metabolic function in patients with schizophrenia, predictors of metabolic dysregulation, and association with psychopathology: a systematic review and network meta-analysis

    Authors: , , , , , , , , , , - The Lancet Psychiatry 2019 cited by 1,008

  5. Explainable artificial intelligence for mental health through transparency and interpretability for understandability

    Authors: , , , - npj Digital Medicine, npj Digit. Medicine 2023 cited by 216

  6. Imputing missing standard deviations in meta-analyses can provide accurate results

    Authors: , , , , - Journal of Clinical Epidemiology 2005 cited by 1,561

  7. Comparative effects of pharmacological interventions for the acute and long-term management of insomnia disorder in adults: a systematic review and network meta-analysis

    Authors: , , , , , , , , , , , , , , , , - The Lancet 2022 cited by 413

  8. Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis

    Authors: , , , , , , , , , , , , , , - The Lancet 2013 cited by 2,537

  9. Conceptual and Technical Challenges in Network Meta-analysis

    Authors: , , , - Annals of Internal Medicine 2013 cited by 1,057

  10. Association of Cannabis Use in Adolescence and Risk of Depression, Anxiety, and Suicidality in Young Adulthood

    Authors: , , , , , , , , , , - JAMA Psychiatry 2019 cited by 894

  11. A network meta‐analysis of the effects of psychotherapies, pharmacotherapies and their combination in the treatment of adult depression

    Authors: , , , , , - World Psychiatry 2020 cited by 533

  12. Psychotherapies for depression: a network meta‐analysis covering efficacy, acceptability and long‐term outcomes of all main treatment types

    Authors: , , , , , , , , - World Psychiatry 2021 cited by 360

  13. Comparative efficacy and tolerability of 32 oral and long-acting injectable antipsychotics for the maintenance treatment of adults with schizophrenia: a systematic review and network meta-analysis

    Authors: , , , , , , , , , , , - The Lancet 2022 cited by 216

  14. Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis

    Authors: , , , , , , , , , , , , , , , , , , - The Lancet 2016 cited by 737

  15. Sixty Years of Placebo-Controlled Antipsychotic Drug Trials in Acute Schizophrenia: Systematic Review, Bayesian Meta-Analysis, and Meta-Regression of Efficacy Predictors

    Authors: , , , , , , , , , , , , - American Journal of Psychiatry 2017 cited by 536

  16. Effectiveness and Acceptability of Cognitive Behavior Therapy Delivery Formats in Adults With Depression

    Authors: , , , , - JAMA Psychiatry 2019 cited by 579

  17. Digital mental health: challenges and next steps

    Authors: , , , , , , , , , , , , - BMJ Mental Health 2023 cited by 209

  18. Comparative efficacy and acceptability of antidepressants, psychotherapies, and their combination for acute treatment of children and adolescents with depressive disorder: a systematic review and network meta-analysis

    Authors: , , , , , , , , , , , , , , , , , , , , - The Lancet Psychiatry 2020 cited by 351

  19. Dose equivalents of antidepressants: Evidence-based recommendations from randomized controlled trials

    Authors: , , , , , , , , - Journal of Affective Disorders 2015 cited by 393

  20. National Prescription Patterns of Antidepressants in the Treatment of Adults With Major Depression in the US Between 1996 and 2015: A Population Representative Survey Based Analysis

    Authors: , , , , - Frontiers in Psychiatry 2020 cited by 210

  21. Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for Psychopharmacology

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Psychopharmacology 2016 cited by 1,296

  22. Polyunsaturated fatty acids metabolism, purine metabolism and inosine as potential independent diagnostic biomarkers for major depressive disorder in children and adolescents

    Authors: , , , , , , , , , , , , , , - Molecular Psychiatry 2018 cited by 181

  23. Optimal Dose of Selective Serotonin Reuptake Inhibitors, Venlafaxine, and Mirtazapine in Major Depression: A Systematic Review and Dose-Response Meta-Analysis

    Authors: , , , , , - FOCUS The Journal of Lifelong Learning in Psychiatry 2019 cited by 317

  24. Lithium in the prevention of suicide in mood disorders: updated systematic review and meta-analysis

    Authors: , , , - BMJ 2013 cited by 888